A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS

BACKGROUND: Tofacitinib is an oral, small molecule JAK inhibitor approved in several countries for the treatment of ulcerative colitis (UC). Efficacy and safety of tofacitinib as UC induction and maintenance therapy were evaluated in Phase (P)2(1) and P3(2) randomized, placebo-controlled studies, an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Can Assoc Gastroenterol
Main Authors: Sandborn, W J, Panés, J, Panaccione, R, D’Haens, G, Sands, B E, Su, C, Moscariello, M, Jones, T V, Pedersen, R D, Friedman, G S, Lawendy, N, Chan, G
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Posters Of Distinction
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512642/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados